LivaNova PLC (LIVN) financial statements (2022 and earlier)

Company profile

Business Address 20 EASTBOURNE TERRACE
LONDON, W2 6LG
State of Incorp.
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments208253 479440
Cash and cash equivalents208253 479440
Receivables185184 256282276
Inventory, net of allowances, customer advances and progress billings106127 154144183
Inventory106127 154144183
Prepaid expense3860 474661
Derivative instruments and hedges, assets107     
Disposal group, including discontinued operation 71  251 
Other undisclosed current assets3625 305360
Total current assets:679719 533870620
Noncurrent Assets
Operating lease, right-of-use asset4151 
Property, plant and equipment150164 191192224
Long-term investments and receivables1731 253461
Long-term investments1731 253461
Intangible assets, net (including goodwill), including:1,0121,034 1,3681,2311,301
Goodwill900922 957784692
Intangible assets, net (excluding goodwill)   412446609
Other undisclosed intangible assets, net (including goodwill)112112    
Derivative instruments and hedges 72    
Deferred income tax assets23 
Other noncurrent assets1311 576131
Deferred tax assets, net  6
Other undisclosed noncurrent assets288326 427101 
Total noncurrent assets:1,5221,692 2,0161,6341,723
TOTAL ASSETS:2,2012,411 2,5502,5042,343
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities172186 224178191
Accounts payable6874 778693
Accrued liabilities8995 1247976
Taxes payable1516 231322
Debt23013 298448
Deferred compensation liability7952 836678
Derivative instruments and hedges, liabilities183     
Estimated litigation liability3329 162  
Disposal group, including discontinued operation 30  78 
Total current liabilities:697309 497406317
Noncurrent Liabilities
Long-term debt and lease obligation46685 1406275
Long-term debt, excluding current maturities10642 1406275
Operating lease, liability3642 
Liabilities, other than long-term debt87218 18097244
Deferred revenue109 
Deferred tax liabilities, net  173
Deferred income tax liabilities89 
Liability, pension and other postretirement and postemployment benefits1921 252832
Estimated litigation liability 8 132  
Other liabilities5050 236939
Derivative instruments and hedges, liabilities 122    
Other undisclosed noncurrent liabilities7781 230123 
Total noncurrent liabilities:209983 549283319
Total liabilities:9061,293 1,046689636
Stockholders' equity
Stockholders' equity attributable to parent1,2951,119 1,5041,8151,707
Common stock8276 767575
Treasury stock, value(1)(1) (1)(0)(5)
Additional paid in capital2,1181,768 1,7051,7351,720
Accumulated other comprehensive income (loss)(7)28 (24)45(68)
Accumulated deficit(898)(752) (252)(40)(15)
Total stockholders' equity:1,2951,119 1,5041,8151,707
TOTAL LIABILITIES AND EQUITY:2,2012,411 2,5502,5042,343

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues1,035934 1,1071,0121,214
Revenue, net1,0121,214
Cost of revenue
(Cost of Goods and Services Sold)
(329)(308) (362)(353)(472)
Other undisclosed gross profit    (7)(38)
Gross profit:706626 745652704
Operating expenses(707)(804) (651)(556)(732)
Other undisclosed operating loss (92) (342)  
Operating income (loss):(1)(270) (248)96(28)
Nonoperating income (expense)80 1(7)2
Investment income, nonoperating90 1(7)2
Foreign currency transaction loss, before tax(1)     
Interest and debt expense(110)(41) (10)(8)(11)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(21)(33) 10  
Income (loss) from continuing operations before equity method investments, income taxes:(124)(344) (247)81(37)
Loss from equity method investments(0)(0) (1)  
Other undisclosed income from continuing operations before income taxes   1413
Income (loss) from continuing operations before income taxes:(125)(344) (247)121(33)
Income tax expense (benefit)(11)1 70(50)(7)
Income (loss) from continuing operations:(136)(344) (178)71(40)
Loss from discontinued operations    (94) 
Net loss:(136)(344) (178)(22)(40)
Other undisclosed net loss attributable to parent (1) (12)(3)(23)
Net loss available to common stockholders, diluted:(136)(345) (189)(25)(63)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(136)(344) (178)(22)(40)
Other comprehensive loss     (14)
Comprehensive loss:(136)(344) (178)(22)(54)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(35)46 (81)111(23)
Comprehensive income (loss), net of tax, attributable to parent:(171)(298) (259)89(77)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: